Download the full report here.
The growth of Big Data and analytics is boosting interest in High Performance Computing (HPC) and supercomputing, resource-intensive computing technologies that have been focused in research universities and government laboratories.
“Advances in genome sequencing technology mean that the sheer volume of data and analysis continues to strain legacy infrastructures,” said Chris Dwan, who led research computing at both the Broad Institute and the New York Genome Center.
“The shortest path to breakthroughs in medicine is to put the very best technologies in the hands of the researchers, on their own schedule,” Dwan continued. “Combining the strengths of Cray and Markley into supercomputing as a service does exactly that.”
Focus on Life Sciences
“Cray and Markley are changing the game,” said Fred Kohout, Cray’s senior vice president of products and chief marketing officer. “Now any company that has needed supercomputing capability to address their business-critical research and development needs can easily and efficiently harness the power of a Cray supercomputer.”
The new service will feature the Cray Urika-GX for life sciences – a complete, pre-integrated hardware-software solution. In addition, Cray has integrated the Cray Graph Engine (CGE) with essential pattern-matching capability and tuned it to leverage the Urika-GX platform.
Cray and Markley have plans for the collaboration to quickly expand and include Cray’s full range of infrastructure solutions.
Cray Inc. has a lengthy legacy as a pioneer in supercomputing. Its predecessor firm, Cray Research, was founded in 1972 by computer designer Seymour Cray.
